EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cellular plasticity as a dynamic regulator of death sensitivity and drug resistance in cancer

Shubhada Malode, Sharav Desai, Divyesh Mhatre, Vipul Patel, Falguni Chhajed, Sakshi Surade

Cell Death · 2026-07 · 2 (3) · 100016

DOI: 10.1016/j.celld.2026.100016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Death, 2026-07. Verfasst von Shubhada Malode und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic resistance continues to be a major obstacle to long-term cancer treatment, regardless of the improvement of chemotherapy, radiotherapy, and targeted therapies. There is an emerging body of evidence that resistance is caused not only by irreversible genetic changes but also by dynamic, reversible adaptations collectively referred to as cellular plasticity. Cellular plasticity facilitates the conversion of the cancer cell's phenotypic state to respond to therapeutic stress conditions and, consequently, changes the survival signals and sensitivity of regulated cell death. This review describes the mechanistic interplay between cellular plasticity and death sensitivity, in which adaptive transitions favoring tumor cells in response to treatment induce drug resistance and promote tumor cell survival. Examples of important plasticity programs include epithelial-mesenchymal plasticity (EMP), cancer stem cell (CSC) phenotypes, and drug-tolerant persister (DTP) states, which enable tumor cells to temporarily escape cytotoxic stress through coordinated transcriptional, metabolic, and epigenetic reprogramming. The adaptive states are linked to diminished apoptotic priming, stimulated cytoprotective autophagy, altered vulnerability to ferroptosis, and senescence-like survival. Even though it is reversible in the early stages, it can progress to permanent resistance through the accumulation of stable genetic and epigenetic changes that result from prolonged persistence. Attacking vulnerabilities associated with these adaptive states, e.g., epigenetic control, metabolic addictions, ferroptotic programs, and stem-like signaling, might be promising strategies to eliminate therapy-resistant tumor cells and enhance overall therapeutic responses.

Zitieren

APA

Malode, S., Desai, S., Mhatre, D., Patel, V., Chhajed, F., & Surade, S. (2026). Cellular plasticity as a dynamic regulator of death sensitivity and drug resistance in cancer. Cell Death, 2(3), 100016. https://doi.org/10.1016/j.celld.2026.100016

Vancouver

Malode S, Desai S, Mhatre D, Patel V, Chhajed F, Surade S. Cellular plasticity as a dynamic regulator of death sensitivity and drug resistance in cancer. Cell Death. 2026;2(3):100016. doi:10.1016/j.celld.2026.100016

BibTeX
@article{Malode2026,
  author = {Malode, Shubhada and Desai, Sharav and Mhatre, Divyesh and Patel, Vipul and Chhajed, Falguni and Surade, Sakshi},
  title = {Cellular plasticity as a dynamic regulator of death sensitivity and drug resistance in cancer},
  journal = {Cell Death},
  year = {2026},
  volume = {2},
  number = {3},
  pages = {100016},
  doi = {10.1016/j.celld.2026.100016}
}
Kostenlos starten →